Nishioka C, Ikezoe T, Yang J, Yokoyama A. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells. PLoS ONE. 2015;10:e0125017 pubmed publisher

Cho M, Kwon S, Kim C, Lee Y, Nam H, Lee S. Overexpression of KAI1 Protein in Diabetic Skin Tissues. Arch Plast Surg. 2014;41:248-52 pubmed publisher

Wang G, Jiang H, Xu H, Sun Q, Zhou Y, Xiang P, et al. Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma. Oncol Lett. 2015;9:1681-1686 pubmed

Yusenko M, Kovacs G. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Histopathology. 2009;55:687-95 pubmed publisher

Ilhan O, Çelık S, Han U, Onal B. Use of KAI-1 as a prognostic factor in gastric carcinoma. Eur J Gastroenterol Hepatol. 2009;21:1369-72 pubmed publisher

Li M, Hou X, Shao J, Tang C, Li D. The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy. Biol Reprod. 2010;82:968-79 pubmed publisher

Maloney S, Fernandes B, Penteado R, Antecka E, Bravo-Filho V, Sanft D, et al. Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma. J Ophthalmol. 2013;2013:683963 pubmed publisher

Li M, Tang C, Du M, Fan D, Zhao H, Xu B, et al. CXCL12 controls over-invasion of trophoblasts via upregulating CD82 expression in DSCs at maternal-fetal interface of human early pregnancy in a paracrine manner. Int J Clin Exp Pathol. 2011;4:276-86 pubmed